NEUARTIGE INFLUENZA-ANTIGENE

European patent · EP3423090 · Deleted

Register entry

Publication number
EP3423090
Application number
EP17708482
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 2, 2017
Published
Jan 9, 2019
Granted
Aug 30, 2023
Deleted
Oct 23, 2024
Reason
Annual fee unpaid
IPC classes
A61K 39/12 (2006.01)
A61K 39/145 (2006.01)
C07K 14/005 (2006.01)
Priority
GB 201603625 02.03.2016
PCT application
PCT/EP2017/054843 02.03.2017
PCT publication
WO2017/149054 08.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2024

  2. Jul 10, 2024

    Change

    Published in Swissreg on 10.07.2024

  3. Aug 30, 2023

    Granted

    Published in Swissreg on 30.08.2023

Parties

Holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Inventor

VASSILEV, Ventzislav Bojidarov

B-1330 Rixensart, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.